Clinical Trial

An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants

Name: An Open-Label Drug Interaction Clinical Study to Evaluate Itraconazole, Rifampin, Midazolam and SIM0270 in Chinese Healthy Adult Participants — clinical trial record (NCT07357610)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: SIM0270-104

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is an open-label, fixed-sequence, two-period Phase 1 clinical trial in healthy adult Chinese participants with a total of 3 cohorts, 16-20 healthy adult Chinese participants are planned to be enrolled in each cohort.

Trial Details

NCT Number	NCT07357610
Lead Sponsor	Jiangsu Simcere Pharmaceutical Co., Ltd.
Conditions	Healthy Adult Participants
Enrollment	60 participants
Start Date	2026-01-05
Primary Completion	2026-10-30 (estimated)
Study Completion	2026-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-01-22